市場調査レポート
商品コード
1389605

マイクロキャリアの市場規模・予測、世界・地域のシェア、動向、成長機会分析:製品別、装置別、用途別、エンドユーザー別、地域別

Microcarriers Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis By Product, Equipment, Application, End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 185 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
マイクロキャリアの市場規模・予測、世界・地域のシェア、動向、成長機会分析:製品別、装置別、用途別、エンドユーザー別、地域別
出版日: 2023年11月07日
発行: The Insight Partners
ページ情報: 英文 185 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マイクロキャリア市場は、2022年の16億2,500万米ドルから2030年には41億7,800万米ドルに達すると予測されています。当レポートでは、市場を牽引する主な要因や、主な発展を遂げた著名なプレイヤーをハイライトしています。市場成長を促進する主な要因は、がんや感染症の罹患率上昇に伴う細胞療法の必要性、細胞・遺伝子治療製造のアウトソーシング人気の高まりです。しかし、生物製剤や細胞ベースの治療法のコストが高いことが市場成長の妨げとなっています。

マイクロキャリア市場で事業を展開する企業は、提携、拡大、合意、パートナーシップ、新製品発売などの戦略的開拓に注力しており、売上の向上、地理的範囲の拡大、既存顧客ベースよりも多くの顧客に対応するための能力強化に貢献しています。

製品別に見ると、マイクロキャリア市場はマイクロキャリアビーズと培地・試薬に分けられます。2022年には、マイクロキャリアビーズセグメントが最大の市場シェアを占め、2022-2030年のCAGRは12.8%と最速になると推定されます。細胞生物学研究の拡大、再生医療やバイオ医薬品の需要、複数のメーカーやサプライヤーの存在が、市場の大幅な成長に寄与しています。マイクロキャリア技術の広範な製品提供と継続的な発展が、主要市場プレーヤーの成長に有利な機会を提供しています。Sartorius AGなどの主要企業は、動物性成分を含まず、タンパク質がコーティングされたマイクロキャリアビーズを提供しています。

装置に基づくと、マイクロキャリア市場はバイオリアクター、培養容器、その他に区分されます。2022年には、バイオリアクターセグメントが最大の市場シェアを占め、2022-2030年のCAGRは12.8%と最も速いと推定されています。バイオリアクターは、生物学的反応が行われる製造装置または容器であり、制御された条件下で適切な環境で酵母、細菌、動物細胞などの微生物を増殖させるために使用されます。細胞の増殖や製品の形成に適した環境を維持します。マイクロキャリアベースのバイオリアクターは、細胞の増殖や品質、代謝物の分析をリアルタイムでオフラインモニタリングすることができ、エラーを検出して即座に修正するために活用することができます。

マイクロキャリア市場は用途別に、バイオ医薬品生産、細胞・遺伝子治療、組織工学・再生医療、その他に区分されます。2022年には、バイオ医薬品生産分野が最大の市場シェアを占め、2022-2030年のCAGRは13.1%と最も速いと推定されます。バイオ医薬品生産セグメントは、さらに治療薬生産とワクチン生産に細分化されます。マイクロキャリアはバイオ医薬品業界で確立された技術であり、攪拌槽型バイオリアクターと組み合わせることで、接着細胞の大量生産に必要な環境を提供できます。マイクロキャリアの製造に使用される生分解性材料は、in vitroでの疾患モデリングを解決する能力を持っています。マイクロキャリアは、制御可能な生分解のスペクトルを拡大することから、バイオ医薬品産業への応用が期待されています。

エンドユーザーに基づくと、マイクロキャリア市場は製薬・バイオテクノロジー企業、受託研究機関および受託製造機関(CMO)、学術・研究機関に区分されます。製薬・バイオテクノロジー企業セグメントが2022年の市場で最大のシェアを占めています。さらに、同セグメントは予測期間中、市場で最も高いCAGR 12.9%を記録すると予測されています。製薬会社は、医薬品製造全体の中で大きなシェアを占めています。医薬品製造プロセスは、多くの場合、インスリンやヒト成長ホルモンなどの製品を製造するために細菌を使用するバイオテクノロジーの原理に基づいています。医薬品・バイオテクノロジー産業は、主に研究開発活動の活発化と、微生物ベースの新製品イントロダクションの規制当局の承認により、過去10年間で大きな成長を遂げました。このような大規模な技術革新は、今後数年間、製薬およびバイオテクノロジー製造におけるバイオリアクターの採用を促進し、最終的には製薬およびバイオテクノロジー分野のマイクロキャリア市場の成長に有利に働くと予測されています。

米国食品医薬品局(USFDA)、臨床経済審査研究所(ICER)、疾病対策予防センター(CDC)は、マイクロキャリア市場に関する報告書を作成する際に参照した一次情報および二次情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 マイクロキャリア市場情勢

  • PEST分析
    • 世界のPEST分析

第5章 マイクロキャリア市場- 主要産業力学

  • 主な市場促進要因
    • がんと感染症の増加に伴う細胞治療のニーズ
    • 細胞・遺伝子治療製造のアウトソーシング人気の高まり
  • 市場抑制要因
    • 生物製剤と細胞ベースの治療薬の高コスト
  • 市場機会
    • マイクロキャリアメーカーによる戦略的取り組みと革新的製品
  • 今後の動向
    • 細胞・遺伝子治療製造サービスの自動化
  • 影響分析

第6章 マイクロキャリア市場-世界市場分析

  • マイクロキャリア市場の収益、2022年~2030年

第7章 マイクロキャリア市場-2030年までの収益と予測:製品別

  • マイクロキャリア市場の収益シェア、製品別、2022年および2030年(%)
  • マイクロキャリアビーズ
  • 培地・試薬

第8章 マイクロキャリア市場-2030年までの収益と予測:装置別

  • マイクロキャリア市場の収益シェア、装置別、2022年および2030年(%)
  • バイオリアクター
  • 培養容器
  • その他

第9章 マイクロキャリア市場-2030年までの収益と予測:用途別

  • マイクロキャリア市場の収益シェア、用途別、2022年および2030年(%)
  • バイオリアクター
  • バイオ医薬品生産
  • 細胞・遺伝子治療
  • 組織工学・再生医療
  • その他

第10章 マイクロキャリア市場-2030年までの収益と予測:エンドユーザー別

  • マイクロキャリア市場の収益シェア、エンドユーザー別、2022年および2030年(%)
  • 製薬企業・バイオテクノロジー企業
  • CRO・CMO
  • 学術・研究機関

第11章 マイクロキャリア市場-2030年までの収益と予測:地域別分析

  • 北米
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • その他欧州
  • アジア太平洋
    • その他アジア太平洋
  • 中東・アフリカ
    • その他中東・アフリカ
  • 中南米
    • その他中南米

第12章 マイクロキャリア市場-業界情勢

  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Teijin Ltd
  • Bio-Rad Laboratories Inc
  • denovoMATRIX GmbH
  • Sartorius AG
  • Danaher Corp
  • Corning Inc
  • Eppendorf SE
  • Percell Biolytica AB
  • Asahi Kasei Corp
  • Polysciences Inc

第14章 付録

図表

List Of Tables

  • Table 1. Microcarriers Market Segmentation
  • Table 2. North America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 3. North America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 4. North America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 5. North America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 6. North America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 7. US Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 8. US Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 9. US Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 10. US Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 11. US: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 12. Canada Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 13. Canada Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 14. Canada Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 15. Canada Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 16. Canada: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 17. Mexico Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 18. Mexico Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 19. Mexico Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 20. Mexico Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 21. Mexico: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 22. Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 23. Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 24. Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 25. Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 26. Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 27. Germany Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 28. Germany Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 29. Germany Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 30. Germany Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 31. Germany: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 32. UK Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 33. UK Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 34. UK Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 35. UK Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 36. UK: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 37. France Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 38. France Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 39. France Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 40. France Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 41. France: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 42. Italy Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 43. Italy Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 44. Italy Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 45. Italy Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 46. Italy: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 47. Spain Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 48. Spain Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 49. Spain Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 50. Spain Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 51. Spain: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 52. Rest of Europe Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 53. Rest of Europe Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 54. Rest of Europe Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 55. Rest of Europe Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 56. Rest of Europe: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 57. Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 58. Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 59. Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 60. Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 61. Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 62. China Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 63. China Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 64. China Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 65. China Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 66. China: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 67. Japan Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 68. Japan Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 69. Japan Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 70. Japan Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 71. Japan: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 72. India Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 73. India Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 74. India Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 75. India Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 76. India: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 77. Australia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 78. Australia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 79. Australia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 80. Australia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 81. Australia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 82. South Korea Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 83. South Korea Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 84. South Korea Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 85. South Korea Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 86. South Korea: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 87. Rest of Asia Pacific Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 88. Rest of Asia Pacific Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 89. Rest of Asia Pacific Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 90. Rest of Asia Pacific Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 91. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 92. Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 93. Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 94. Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 95. Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 96. Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 97. Saudi Arabia Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 98. Saudi Arabia Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 99. Saudi Arabia Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 100. Saudi Arabia Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 101. Saudi Arabia: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 102. South Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 103. South Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 104. South Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 105. South Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 106. South Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 107. UAE Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 108. UAE Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 109. UAE Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 110. UAE Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 111. UAE: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 112. Rest Middle East & Africa Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 113. Rest Middle East & Africa Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 114. Rest Middle East & Africa Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 115. Rest Middle East & Africa Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 116. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 117. South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 118. South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 119. South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 120. South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 121. South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 122. Brazil Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 123. Brazil Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 124. Brazil Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 125. Brazil Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 126. Brazil: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 127. Argentina Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 128. Argentina Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 129. Argentina Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 130. Argentina Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 131. Argentina: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 132. Rest Of South & Central America Microcarriers Market, by Product - Revenue and Forecast to 2030 (USD Million)
  • Table 133. Rest Of South & Central America Microcarriers Market, by Equipment - Revenue and Forecast to 2030 (USD Million)
  • Table 134. Rest Of South & Central America Microcarriers Market, by Application - Revenue and Forecast to 2030 (USD Million)
  • Table 135. Rest Of South & Central America Microcarriers Market, by Biopharmaceutical Production - Revenue and Forecast to 2030 (USD Million)
  • Table 136. Rest Of South & Central America: Microcarriers Market Revenue and Forecast To 2030 (US$ Mn) - End User
  • Table 137. Recent Organic Growth Strategies in Microcarriers Market
  • Table 138. Recent Inorganic Growth Strategies in the Microcarriers Market
  • Table 139. Glossary of Terms

List Of Figures

  • Figure 1. Microcarriers Market Segmentation, By Region
  • Figure 2. Key Insights
  • Figure 3. Global - PEST Analysis
  • Figure 4. Microcarriers Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints for Microcarriers Market
  • Figure 6. Microcarriers Market Revenue (US$ Mn), 2022 - 2030
  • Figure 7. Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • Figure 11. Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • Figure 22. Pharmaceutical and Biotechnology Companies: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 23. Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 24. Academic and Research Institutes: Microcarriers Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 25. Microcarriers Market, 2022 ($Mn)
  • Figure 26. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. North America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 28. US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Microcarriers Market, 2022 ($Mn)
  • Figure 32. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Europe: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 34. Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
  • Figure 35. UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
  • Figure 38. Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Microcarriers Market, 2022 ($Mn)
  • Figure 41. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Asia Pacific: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 43. China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
  • Figure 44. Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 47. South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Microcarriers Market, 2022 ($Mn)
  • Figure 50. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Middle East & Africa: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 52. Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
  • Figure 53. South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
  • Figure 56. Microcarriers Market, 2022 ($Mn)
  • Figure 57. Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. South & Central America: Microcarriers Market, By Countries, 2022 And 2030 (%)
  • Figure 59. Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
  • Figure 60. Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: TIPBT00002183

According to our latest study on "Microcarriers Market Forecast to 2030 - Global Analysis -Product, Equipment, Application, and End User," the market is expected to reach US$ 4.178 billion in 2030 from US$ 1.625 billion in 2022. The report highlights the key factors driving the market and prominent players with their developments. Key factors driving the market growth are need for cell therapies with rising incidence of cancer and infectious diseases, and increasing popularity of outsourcing cell and gene therapy manufacturing boost the market growth. However, the high cost of biologics and cell-based therapies hampers the market growth.

Companies operating in the microcarriers market focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches, which help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the microcarriers market are mentioned below:

In October 2023, Kuraray Co., Ltd. developed PVA hydrogel microcarriers for cell cultures used in regenerative medicine. The product is scheduled for launch in January 2024 in Japan and overseas, beginning in the US.

In June 2023, Teijin Frontier introduced new nonwoven microcarriers that enable speedy, large-scale, high-quality cell culture. The new nonwoven microcarriers combine Teijin Frontier's proprietary fiber process and nonwoven design technology, and fiber-related biomedical expertise by the Faculty of Engineering, University of Fukui, Japan.

In October 2023, Semarion, unveiled the Early Adopter Programme for its SemaCyte Microcarrier Platform. SemaCytes developed by Semarion are cell carrier materials created using microchip fabrication technologies, nanomagnetism, and smart materials. These assaying microcarriers are flat and function as ultraminiaturized, magnetically steerable wells that carry small colonies of adherent cells into suspension to improve cell-based experiments.

In January 2022, FUJIFILM Corporation announced its plan to acquire a cell therapy manufacturing facility from Atara Biotherapeutics, Inc. The facility is readily expandable and flexible to produce clinical and commercial cell therapies, including allogeneic T-cell and CAR T immunotherapies.

In January 2021, Thermo Fisher Scientific Inc acquired Henogen S.A., a Belgium-based viral vector manufacturing business of Groupe Novasep SAS. Henogen provides vaccine and therapeutics manufacturing services to biotechnology companies and large biopharmaceutical customers. With this acquisition, Thermo Fisher Scientific expanded its capabilities in the cell and gene vaccines and therapies category.

Therefore, introducing products such as PVA hydrogel microcarriers, nonwoven microcarriers, and SemaCyte microcarrier platform, and the initiation of new businesses through collaborations and partnerships to remain competitive in the market would create significant growth opportunities in the microcarriers market.

Based on product, the microcarriers market is divided into microcarrier beads and media & reagents. In 2022, the microcarrier beads segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Growing cell biology research, demand for regenerative medicines and biopharmaceuticals, and the presence of multiple manufacturers and suppliers contribute to the considerable market growth. Extensive product offerings and continuous developments in microcarrier technology offer lucrative opportunities for the growth of key market players. Major companies such as Sartorius AG offer microcarrier beads that are free of animal components and proteins coated.

Based on equipment, the microcarriers market is segmented into bioreactors, culture vessels, and others. In 2022, the bioreactors segment held the largest market share, and same is estimated to register the fastest CAGR of 12.8% during 2022-2030. Bioreactors are manufacturing devices or vessels in which biological reactions are carried out; they are used to grow microorganisms such as yeast, bacteria, or animal cells in an appropriate environment under controlled conditions. They maintain a supportable environment for cell growth and product formation. A microcarrier-based bioreactor allows real-time off-line monitoring of cell growth and quality and metabolite analyses, which can be utilised to detect errors and rectify them immediately.

Based on application, the microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and others. In 2022, the biopharmaceutical production segment held the largest market share, and same is estimated to register the fastest CAGR of 13.1% during 2022-2030. Biopharmaceutical production segment is further subsegmented into therapeutic production and vaccine production. Microcarriers are an established technology in the biopharmaceutical industry, which, in combination with stirred-tank bioreactors, can provide the necessary environment for large-scale production of adherent cells. Biodegradable materials used in the production of microcarriers have the capability to solve in vitro disease modeling. Microcarriers find applications in biopharmaceutical industries as they expand the spectrum of controllable biodegradation.

Based on end user, the microcarriers market is segmented pharmaceutical and biotechnology companies, contract research organizations and contract manufacturing organizations (CMOs), and academic and research institutes. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022. Moreover, the same is estimated to register the highest CAGR of 12.9% in the market during the forecast period. Pharmaceutical companies hold a major share of the total medicine production. Pharmaceutical manufacturing processes are often based on biotechnology principles that involve the use of bacteria to produce insulin, human growth hormone, etc., products. The pharmaceutical and biotechnological industries have witnessed extensive growth in the past decade mainly owing to increased R&D activities and regulatory approvals for the introduction of new microbe-based products. Such a massive scale of innovation is projected to drive the adoption of bioreactors in pharmaceutical and biotechnological manufacturing in the coming years, eventually favoring the microcarriers market growth for the pharmaceutical and biotechnological segment.

United States Food and Drug Administration (USFDA), Institute for Clinical and Economic Review (ICER), Centers for Disease Control and Prevention (CDC), are a few key primary and secondary sources referred to while preparing the report on the microcarriers market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Microcarriers Market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the Microcarriers Market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Microcarriers Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Microcarriers Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Need for Cell Therapies with Rising Incidence of Cancer and Infectious Diseases
    • 5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Biologics and Cell-based Therapies
  • 5.3 Market Opportunities
    • 5.3.1 Strategic Initiatives and Innovative Products by Microcarrier Manufacturers
  • 5.4 Future Trends
    • 5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
  • 5.5 Impact Analysis

6. Microcarriers Market - Global Market Analysis

  • 6.1 Microcarriers Market Revenue (US$ Mn), 2022 - 2030

7. Microcarriers Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Microcarriers Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Microcarrier Beads
    • 7.3.1 Overview
    • 7.3.2 Microcarrier Beads: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Media and Reagents
    • 7.4.1 Overview
    • 7.4.2 Media and Reagents: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

8. Microcarriers Market - Revenue and Forecast to 2030 - by Equipment

  • 8.1 Overview
  • 8.2 Microcarriers Market Revenue Share, by Equipment 2022 & 2030 (%)
  • 8.3 Bioreactors
    • 8.3.1 Overview
    • 8.3.2 Bioreactors: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Culture Vessels
    • 8.4.1 Overview
    • 8.4.2 Culture Vessels: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

9. Microcarriers Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 Microcarriers Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Biopharmaceutical Production
    • 9.3.1 Overview
    • 9.3.2 Biopharmaceutical Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.3 Therapeutic Protein Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
    • 9.3.4 Vaccine Production: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Cell and Gene Therapy
    • 9.4.1 Overview
    • 9.4.2 Cell and Gene Therapy: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Tissue Engineering and Regenerative Medicine
    • 9.5.1 Overview
    • 9.5.2 Tissue Engineering and Regenerative Medicine: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Microcarriers Market - Revenue and Forecast to 2030 (US$ Million)

10. Microcarriers Market Revenue and Forecasts To 2030 - End User

  • 10.1 Overview
  • 10.2 Global Microcarriers Market Share by End User - 2022 & 2030 (%)
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Overview
    • 10.3.2 Pharmaceutical and Biotechnology Companies: Microcarriers Market- Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Contract Research Organizations and Contract Manufacturing Organizations
    • 10.4.1 Overview
    • 10.4.2 Contract Research Organizations and Contract Manufacturing Organizations: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Academic and Research Institutes
    • 10.5.1 Overview
    • 10.5.2 Academic and Research Institutes: Microcarriers Market- Revenue and Forecast to 2028 (US$ Million)

11. Microcarriers Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 11.1 North America Microcarriers Market, Revenue and Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America: Microcarriers Market, by Product
    • 11.1.4 North America: Microcarriers Market, by Equipment
    • 11.1.5 North America: Microcarriers Market, by Application
      • 11.1.5.1 North America: Microcarriers Market, by Biopharmaceutical Production
    • 11.1.6 North America: Microcarriers Market, by End User
    • 11.1.7 North America: Microcarriers Market, by Country
      • 11.1.7.1 US
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.1.3 US: Microcarriers Market, by Product
        • 11.1.7.1.4 US: Microcarriers Market, by Equipment
        • 11.1.7.1.5 US: Microcarriers Market, by Application
        • 11.1.7.1.5.1 US: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.1.6 US: Microcarriers Market, by End User
      • 11.1.7.2 Canada
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.2.3 Canada: Microcarriers Market, by Product
        • 11.1.7.2.4 Canada: Microcarriers Market, by Equipment
        • 11.1.7.2.5 Canada: Microcarriers Market, by Application
        • 11.1.7.2.5.1 Canada: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.2.6 Canada: Microcarriers Market, by End User
      • 11.1.7.3 Mexico
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.1.7.3.3 Mexico: Microcarriers Market, by Product
        • 11.1.7.3.4 Mexico: Microcarriers Market, by Equipment
        • 11.1.7.3.5 Mexico: Microcarriers Market, by Application
        • 11.1.7.3.5.1 Mexico: Microcarriers Market, by Biopharmaceutical Production
        • 11.1.7.3.6 Mexico: Microcarriers Market, by End User
  • 11.2 Europe Microcarriers Market, Revenue and Forecast To 2030
    • 11.2.1 Overview
    • 11.2.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe: Microcarriers Market, by Product
    • 11.2.4 Europe: Microcarriers Market, by Equipment
    • 11.2.5 Europe: Microcarriers Market, by Application
      • 11.2.5.1 Europe: Microcarriers Market, by Biopharmaceutical Production
    • 11.2.6 Europe: Microcarriers Market, by End User
    • 11.2.7 Europe: Microcarriers Market, by Country
      • 11.2.7.1 Germany
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: Microcarriers Market Revenue and Forecast to 2030 (GERMANY$ Mn)
        • 11.2.7.1.3 Germany: Microcarriers Market, by Product
        • 11.2.7.1.4 Germany: Microcarriers Market, by Equipment
        • 11.2.7.1.5 Germany: Microcarriers Market, by Application
        • 11.2.7.1.5.1 Germany: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.1.6 Germany: Microcarriers Market, by End User
      • 11.2.7.2 UK
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 UK: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.2.3 UK: Microcarriers Market, by Product
        • 11.2.7.2.4 UK: Microcarriers Market, by Equipment
        • 11.2.7.2.5 UK: Microcarriers Market, by Application
        • 11.2.7.2.5.1 UK: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.2.6 UK: Microcarriers Market, by End User
      • 11.2.7.3 France
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 France: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.3.3 France: Microcarriers Market, by Product
        • 11.2.7.3.4 France: Microcarriers Market, by Equipment
        • 11.2.7.3.5 France: Microcarriers Market, by Application
        • 11.2.7.3.5.1 France: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.3.6 France: Microcarriers Market, by End User
      • 11.2.7.4 Italy
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: Microcarriers Market Revenue and Forecast to 2030 (ITALY$ Mn)
        • 11.2.7.4.3 Italy: Microcarriers Market, by Product
        • 11.2.7.4.4 Italy: Microcarriers Market, by Equipment
        • 11.2.7.4.5 Italy: Microcarriers Market, by Application
        • 11.2.7.4.5.1 Italy: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.4.6 Italy: Microcarriers Market, by End User
      • 11.2.7.5 Spain
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.5.3 Spain: Microcarriers Market, by Product
        • 11.2.7.5.4 Spain: Microcarriers Market, by Equipment
        • 11.2.7.5.5 Spain: Microcarriers Market, by Application
        • 11.2.7.5.5.1 Spain: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.5.6 Spain: Microcarriers Market, by End User
      • 11.2.7.6 Rest of Europe
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.2.7.6.3 Rest of Europe: Microcarriers Market, by Product
        • 11.2.7.6.4 Rest of Europe: Microcarriers Market, by Equipment
        • 11.2.7.6.5 Rest of Europe: Microcarriers Market, by Application
        • 11.2.7.6.5.1 Rest of Europe: Microcarriers Market, by Biopharmaceutical Production
        • 11.2.7.6.6 Rest of Europe: Microcarriers Market, by End User
  • 11.3 Asia Pacific Microcarriers Market, Revenue and Forecast To 2030
    • 11.3.1 Overview
    • 11.3.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific: Microcarriers Market, by Product
    • 11.3.4 Asia Pacific: Microcarriers Market, by Equipment
    • 11.3.5 Asia Pacific: Microcarriers Market, by Application
      • 11.3.5.1 Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
    • 11.3.6 Asia Pacific: Microcarriers Market, by End User
    • 11.3.7 Asia Pacific: Microcarriers Market, by Country
      • 11.3.7.1 China
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: Microcarriers Market Revenue and Forecast to 2030 (CHINA$ Mn)
        • 11.3.7.1.3 China: Microcarriers Market, by Product
        • 11.3.7.1.4 China: Microcarriers Market, by Equipment
        • 11.3.7.1.5 China: Microcarriers Market, by Application
        • 11.3.7.1.5.1 China: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.1.6 China: Microcarriers Market, by End User
      • 11.3.7.2 Japan
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.2.3 Japan: Microcarriers Market, by Product
        • 11.3.7.2.4 Japan: Microcarriers Market, by Equipment
        • 11.3.7.2.5 Japan: Microcarriers Market, by Application
        • 11.3.7.2.5.1 Japan: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.2.6 Japan: Microcarriers Market, by End User
      • 11.3.7.3 India
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.3.3 India: Microcarriers Market, by Product
        • 11.3.7.3.4 India: Microcarriers Market, by Equipment
        • 11.3.7.3.5 India: Microcarriers Market, by Application
        • 11.3.7.3.5.1 India: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.3.6 India: Microcarriers Market, by End User
      • 11.3.7.4 Australia
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.3.7.4.3 Australia: Microcarriers Market, by Product
        • 11.3.7.4.4 Australia: Microcarriers Market, by Equipment
        • 11.3.7.4.5 Australia: Microcarriers Market, by Application
        • 11.3.7.4.5.1 Australia: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.4.6 Australia: Microcarriers Market, by End User
      • 11.3.7.5 South Korea
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.5.3 South Korea: Microcarriers Market, by Product
        • 11.3.7.5.4 South Korea: Microcarriers Market, by Equipment
        • 11.3.7.5.5 South Korea: Microcarriers Market, by Application
        • 11.3.7.5.5.1 South Korea: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.5.6 South Korea: Microcarriers Market, by End User
      • 11.3.7.6 Rest of Asia Pacific
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.3.7.6.3 Rest of Asia Pacific: Microcarriers Market, by Product
        • 11.3.7.6.4 Rest of Asia Pacific: Microcarriers Market, by Equipment
        • 11.3.7.6.5 Rest of Asia Pacific: Microcarriers Market, by Application
        • 11.3.7.6.5.1 Rest of Asia Pacific: Microcarriers Market, by Biopharmaceutical Production
        • 11.3.7.6.6 Rest of Asia Pacific: Microcarriers Market, by End User
  • 11.4 Middle East & Africa Microcarriers Market, Revenue and Forecast To 2030
    • 11.4.1 Overview
    • 11.4.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa: Microcarriers Market, by Product
    • 11.4.4 Middle East & Africa: Microcarriers Market, by Equipment
    • 11.4.5 Middle East & Africa: Microcarriers Market, by Application
      • 11.4.5.1 Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
    • 11.4.6 Middle East & Africa: Microcarriers Market, by End User
    • 11.4.7 Middle East & Africa: Microcarriers Market, by Country
      • 11.4.7.1 Saudi Arabia
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 Saudi Arabia: Microcarriers Market Revenue and Forecast to 2030 (SAUDI ARABIA$ Mn)
        • 11.4.7.1.3 Saudi Arabia: Microcarriers Market, by Product
        • 11.4.7.1.4 Saudi Arabia: Microcarriers Market, by Equipment
        • 11.4.7.1.5 Saudi Arabia: Microcarriers Market, by Application
        • 11.4.7.1.5.1 Saudi Arabia: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.1.6 Saudi Arabia: Microcarriers Market, by End User
      • 11.4.7.2 South Africa
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 South Africa: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.2.3 South Africa: Microcarriers Market, by Product
        • 11.4.7.2.4 South Africa: Microcarriers Market, by Equipment
        • 11.4.7.2.5 South Africa: Microcarriers Market, by Application
        • 11.4.7.2.5.1 South Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.2.6 South Africa: Microcarriers Market, by End User
      • 11.4.7.3 UAE
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.4.7.3.3 UAE: Microcarriers Market, by Product
        • 11.4.7.3.4 UAE: Microcarriers Market, by Equipment
        • 11.4.7.3.5 UAE: Microcarriers Market, by Application
        • 11.4.7.3.5.1 UAE: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.3.6 UAE: Microcarriers Market, by End User
      • 11.4.7.4 Rest Middle East & Africa
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest Middle East & Africa: Microcarriers Market Revenue and Forecast to 2030 (AUSTRALIA$ Mn)
        • 11.4.7.4.3 Rest Middle East & Africa: Microcarriers Market, by Product
        • 11.4.7.4.4 Rest Middle East & Africa: Microcarriers Market, by Equipment
        • 11.4.7.4.5 Rest Middle East & Africa: Microcarriers Market, by Application
        • 11.4.7.4.5.1 Rest Middle East & Africa: Microcarriers Market, by Biopharmaceutical Production
        • 11.4.7.4.6 Rest Middle East & Africa: Microcarriers Market, by End User
  • 11.5 South & Central America Microcarriers Market, Revenue and Forecast To 2030
    • 11.5.1 Overview
    • 11.5.2 Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America: Microcarriers Market, by Product
    • 11.5.4 South & Central America: Microcarriers Market, by Equipment
    • 11.5.5 South & Central America: Microcarriers Market, by Application
      • 11.5.5.1 South & Central America: Microcarriers Market, by Biopharmaceutical Production
    • 11.5.6 South & Central America: Microcarriers Market, by End User
    • 11.5.7 South & Central America: Microcarriers Market, by Country
      • 11.5.7.1 Brazil
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: Microcarriers Market Revenue and Forecast to 2030 (BRAZIL$ Mn)
        • 11.5.7.1.3 Brazil: Microcarriers Market, by Product
        • 11.5.7.1.4 Brazil: Microcarriers Market, by Equipment
        • 11.5.7.1.5 Brazil: Microcarriers Market, by Application
        • 11.5.7.1.5.1 Brazil: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.1.6 Brazil: Microcarriers Market, by End User
      • 11.5.7.2 Argentina
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.2.3 Argentina: Microcarriers Market, by Product
        • 11.5.7.2.4 Argentina: Microcarriers Market, by Equipment
        • 11.5.7.2.5 Argentina: Microcarriers Market, by Application
        • 11.5.7.2.5.1 Argentina: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.2.6 Argentina: Microcarriers Market, by End User
      • 11.5.7.3 Rest Of South & Central America
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest Of South & Central America: Microcarriers Market Revenue and Forecast to 2030 (US$ Mn)
        • 11.5.7.3.3 Rest Of South & Central America: Microcarriers Market, by Product
        • 11.5.7.3.4 Rest Of South & Central America: Microcarriers Market, by Equipment
        • 11.5.7.3.5 Rest Of South & Central America: Microcarriers Market, by Application
        • 11.5.7.3.5.1 Rest Of South & Central America: Microcarriers Market, by Biopharmaceutical Production
        • 11.5.7.3.6 Rest Of South & Central America: Microcarriers Market, by End User

12. Microcarriers Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Organic Growth Strategies
    • 12.2.1 Overview
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview

13. Company Profiles

  • 13.1 Teijin Ltd
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Bio-Rad Laboratories Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 denovoMATRIX GmbH
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Danaher Corp
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Corning Inc
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Eppendorf SE
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Percell Biolytica AB
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Asahi Kasei Corp
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Polysciences Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms